Results 11 to 20 of about 16,889 (275)
Crocin prevents haloperidol-induced orofacial dyskinesia: possible an antioxidant mechanism [PDF]
Objective(s):Long-term treatment with antipsychotics causes serious side effects such as tardive dyskinesia that characterized by abnormal movements in the orofacial region. Oxidative stress in the brain specific area is implicated in the pathophysiology
Marzyeh Kamyar +5 more
doaj +2 more sources
Tardive dyskinesia on clozapine: A case report
Antipsychotic-induced tardive dyskinesia is a potentially irremediable and debilitating condition with the onset most commonly associated with the use of first-generation antipsychotics.
Laila Asmal
doaj +3 more sources
New insights into the mechanism of drug-induced dyskinesia
Dyskinesia is an extrapyramidal movement disorder characterized by involuntary, repetitive, irregular motions that affect the mouth and face and/or the limbs and trunk. Tardive dyskinesia (TD) is a well-known complication of long-term treatment with antipsychotic drugs.
Loonen, Anton J. M. +1 more
openaire +3 more sources
Pathophysiological mechanisms underlying antipsychotic-induced tardive dyskinesia
Purpose. To analyze the results of classical and modern studies reflecting the pathophysiological mechanisms of antipsychotic-induced tardive dyskinesia.Materials and methods. We searched for full-text publications in Russian and English in the databases
E. E. Vayman +3 more
doaj +3 more sources
Vibhash D Sharma, Kelly E Lyons, Rajesh Pahwa Department of Neurology, University of Kansas Medical Center, Kansas City, KS, USA Abstract: Levodopa-induced dyskinesia (LID) is a common motor complication in patients with Parkinson’s disease on ...
Sharma VD, Lyons KE, Pahwa R
doaj +1 more source
Co‐Expression of Tardive Dyskinesia and Drug‐Induced Parkinsonism in Rats Chronically Treated With Haloperidol [PDF]
Aim We aimed to create a rat model of drug‐induced parkinsonism and tardive dyskinesia by chronic administration of haloperidol and examine the expression of direct and indirect pathway markers in the striatum of the model rats.
Iku Kinoshita +7 more
doaj +2 more sources
L-DOPA remains the gold-standard treatment for Parkinson's disease but causes motor fluctuations and dyskinesia. Metabotropic glutamate receptor type 5 (mGluR5) has been proposed as a target for antidyskinetic therapies.
Daniella Rylander +9 more
doaj +2 more sources
Berberis vulgaris alleviates Levodopa-induced dyskinesia in male mice
Introduction: Parkinson’s disease is a chronic debilitating disease and many patients use Levodopa as a major treatment. However, this drug in long-term use causes a serious condition that is known as Levodopa-induced dyskinesia (LID). Berberis vulgaris (
Mokarian Faezeh +2 more
doaj +2 more sources
Failure of pyridoxine to reduce drug-induced dyskinesias [PDF]
The use of pyridoxine seems to be ineffective in reducing tardive dyskinesia.
G E, Crane, I S, Turek, A A, Kurland
openaire +2 more sources
Anticholinergic Agents Can Induce Oromandibular Dyskinesia [PDF]
Background and Purpose: Oromandibular dyskinesia (OMD) can occur spontaneously or they can be induced by the conventional dopamine receptor antagonists.
Hee-Young Shin +2 more
doaj +1 more source

